講演・口頭発表等 - 末永　光邦

1. 藤原俊、加納嘉人、谷本幸介、内藤喬浩、末 永光邦、小林由美、田中陽典、田中敏博、赤星径 一、岡本隆一、浜本康夫. 新規遺伝子パネルを用いた胆道癌における予後 予測遺伝子バイオマーカーの同定. 第22回日本臨床腫瘍学術集会 2025.03 神戸

2. Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, Shingo Dan, Hiroyuki Seimiya, Kensei Yamaguchi. Preclinical analysis and clinical validation to identify biomarkers for trifluridine/tipiracil (FTD/TPI) efficacy with or without bevacizumab in patients with metastatic colorectal cancer.. 2025 ASCO Gastrointestinal Cancers Symposium 2025.01.25 SF, USA

3. Nobuhisa Matsuhashi, Takeshi Yamada, Takeshi Nagasaka, Kozo Kataoka, Kazuhiro Sakamoto, Keiji Koda, Kazuhiro Hiramatsu, Hiroshi Matsuoka, Hidekazu Kuramochi, Hideyuki Ishida, Hajime Yokomizo, Yoshinori Kagawa, Mitsukuni Suenaga, Akihisa Matsuda, Jun Nagata, Kei Ishimaru, Chihiro Kosugi, Takao Takahashi, Hiroshi Yoshida, Keiji Hirata. Impact of RAS and BRAF heterogeneity on the efficacy of EGFR blockade in patients with metastatic colorectal cancer.. 2025 ASCO Gastrointestinal Cancers Symposium 2025.01.25 SF, USA

4. 加納 嘉人, 野地 理夏, 遠山 皓基, 内藤 喬浩, 釘本 琢磨, 黒嶋 雄志, 富岡 寛文, 道 泰之, 藤原 俊, 末永 光邦, 中村 伸, 三浦 雅彦, 原田 浩之, 浜本 康夫. 頭頸部癌におけるリキッドバイオプシーと腫瘍体積量に関する感度の検討(Image Assessment and ctDNA Analysis in Evaluating Tumor Burden in Head and Neck Cancer Treated with ICIs). 日本癌学会総会記事 2024.09.01

5. 藤原俊、加納嘉人、内藤喬浩、青山慧、佐藤信 吾、池田貞勝、森毅彦、末永光邦. Changes in chemotherapy for unresectable or metastatic small bowel adenocarcinoma. 第21 回日本臨床腫瘍学会学術集会 2024.02.22 名古屋国際会議場

6. Mitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, Shingo Dan, Hiroyuki Seimiya, Kensei Yamaguchi. Preclinical analysis and clinical validation to identify biomarkers of regorafenib efficacy in patients with metastatic colorectal cancer.. 2024 ASCO GI Cancers Symposium 2024.01.20 SF, US

7. Mitsukuni Suenaga, Shinichi Yamauchi, Yuya Sato, Rika Noji, Ryo Morikawa, Yoshihito Kano, Masanori Tokunaga, Yusuke Kinugasa. Impact of chemotherapy on COVID-19 vaccination in gastrointestinal cancer patients. 2023 the Japanese Society of Medical Oncology Annual Meeting 2023.03.18 Fukuoka

8. Rika Noji,Ryo Morikawa, Takehiko Mori, Hiroyuki Harada, Mitsukuni Suenaga, Yoshihito Kano. Monitoring for Immunotherapy in Head and Neck Cancer by Liquid Biopsy. 2023 the Japanese Society of Medical Oncology 2023.03.17 Fukuoka

9. Yoshihito Kano, Shingo Sato, Sadakatsu Ikeda, Mitsukuni Suenaga, Takehiko Mori . Establishment of training program for medical oncologist in the era of new medical specialty board system. 2023 the Japanese Society of Medical Oncology 2023.03.17 Fukuoka

10. Ryo Morikawa, Kentaro, Shuntaro Yasuda, Rika Noji, Satoru Aoyama, Yoshihito Kano, Shingo Sato, Sadakatsu Ikeda, Masashi Nagata, Takehiko Mori, Mitsukuni Suenaga. Identification of risk factors for gastrointestinal irAEs associated with immune checkpoint inhibitors. 20th the Japanese Society of Medical Oncology Annual Meeting 2023.03.16 Fukuoka

11. Mitsukuni Suenaga, Shinichi Yamauchi, Yuya Sato, Rika Noji, Ryo Morikawa, Yoshihito Kano, Masanori Tokunaga, Yusuke Kinugasa. Impact of chemotherapy on COVID-19 vaccination in patients with gastrointestinal cancer.. 2023 ASCO GI Cancers Symposium 2023.01.21 SF, US

12. Takeshi Yamada, Nobuhisa Matsuhashi, Takao Takahashi, Keiji Hirata, Takeshi Nagasaka, Yuki Nakamura, Kazuhiro Sakamoto, Keiji Koda, Kazuhiro Hiramatsu, Hiroshi Matsuoka, Hidekazu Kuramochi, Hideyuki Ishida, Kozo Kataoka, Hajime Yokomizo, Yoshinori Kagawa, Mitsukuni Suenaga, Ryo Ohta, Akihisa Matsuda, Hiroshi Yoshida. Impact of RAS and BRAF heterogeneity on the efficacy of EGFR blockade in patients with metastatic colorectal cancer.. 2023 ASCO GI Cancers Symposium 2023.01.21 SF, US

13. Ryo Morikawa, Kentaro Nitta, Shuntaro Yasuda, Rika Noji, Yoshihito Kano, Shingo Sato, Sadakatsu Ikeda, Masashi Nagata, Takehiko Mori, Mitsukuni Suenaga. Identification of risk factors for gastrointestinal irAEs associated with immune checkpoint inhibitors.. 2023 ASCO GI Cancers Symposium 2023.01.19 SF, US

14. Mitsukuni Suenaga, Shinichi Yamauchi, Taiki Masuda, Marie Hanaoka, Noriko Iwata, Yuya Sato, Yuya Sato, Chiharu Tomii, Masanori Tokunaga, Yusuke Kinugasa. COVID-19 vaccination in gastrointestinal cancer patients during chemotherapy at a single institute experience. 2022 the Japanese Society Of Medical Oncology Annual Meeting 2022.02.17 Kyoto

15. 末永光邦、馬島哲夫、若槻尊、清宮啓之. Serum IL-8 level as a candidate prognostic marker of response to anti-angiogenic therapy for metastatic colorectal cancer. 第18 回日本臨床腫瘍学会学術集 2021.02.18 Virtual Congress

16. 上今別府 大作, 若槻 尊, 高張 大亮, 福田 直樹, 佐藤 太龍, 鈴木 健, 大隅 寛木, 中山 厳馬, 末永 光邦, 大木 暁, 小倉 真理子, 篠崎 英司, 山口 研成. 当院でのAFP産生切除不能進行・再発胃癌に対するラムシルマブ併用化学療法の検討(Treatment efficacy of ramucirumab-based chemotherapy in patients with AFP producing gastric cancer). 日本胃癌学会総会記事 2020.03.01

17. Matsusaka Satoshi, Hanna Diana L., Ning Yan, Yang Dongyun, Cao Shu, Berger Martin D., Miyamoto Yuji, Suenaga Mitsukuni, Dan Shingo, Mashima Tetsuo, Seimiya Hiroyuki, Zhang Wu, Lenz Heinz-Josef. 上皮成長因子受容体のmRNA発現　レゴラフェニブから逃れるための分子機序である可能性(Epidermal growth factor receptor mRNA expression: A potential molecular escape mechanism from regorafenib). Cancer Science 2020.02.01

18. Martin D. Berger, Inti Zlobec, Shu Cao, Yuji Miyamoto, Mitsukuni Suenaga, Shivani Soni, Alberto Puccini, Ryuma Tokunaga, Madiha Naseem, Francesca Battaglin, Wu Zhang, Alessandro Lugli, Heinz-Josef Lenz. Polymorphisms of genes encoding for regulatory proteins in the coagulation cascade to predict outcome for stage II and III colon cancer. ASCO-GI 2020.01

19. Suenaga, M., Mashima, T., Kawata, N., Wakatsuki, T., Seimiya, H., Yamaguchi, K.. IL-8 levels as candidate marker of antiangiogenic therapy for metastatic colorectal cancer.. ASCO Gastrointestinal Cancers Symposium 2020.01

20. Suenaga, M., Zhang, W., Mashima, T., Schirripa, M., Cao, S., Okazaki, S., Berger, M. D., Miyamoto, Y., Barzi, A., Lenz, H. J.. Gene polymorphisms of CCL3, CCL4, CCL5, and CCR5 network in metastatic colorectal cancer patients treated with regorafenib. ASCO Gastrointestinal Cancers Symposium 2020.01